These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2563226)

  • 1. Infectious complications of cyclophosphamide treatment for vasculitis.
    Bradley JD; Brandt KD; Katz BP
    Arthritis Rheum; 1989 Jan; 32(1):45-53. PubMed ID: 2563226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.
    Adu D; Pall A; Luqmani RA; Richards NT; Howie AJ; Emery P; Michael J; Savage CO; Bacon PA
    QJM; 1997 Jun; 90(6):401-9. PubMed ID: 9205678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.
    Martin-Suarez I; D'Cruz D; Mansoor M; Fernandes AP; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Aug; 56(8):481-7. PubMed ID: 9306871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener's granulomatosis.
    Bosch X
    Ann Rheum Dis; 1999 Oct; 58(10):644-7. PubMed ID: 10491365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.
    Généreau T; Lortholary O; Leclerq P; Grenet D; Tubéry M; Sicard D; Caubarrère I; Guillevin L
    Br J Rheumatol; 1994 Oct; 33(10):959-62. PubMed ID: 7921758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as an effective and probably safe treatment for granulomatosis with polyangiitis (Wegener's Granulomatosis).
    Tavakolpour S; Alesaeidi S
    Int Immunopharmacol; 2019 May; 70():67-68. PubMed ID: 30785092
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary complications of combination therapy with cyclophosphamide and prednisone.
    Sen RP; Walsh TE; Fisher W; Brock N
    Chest; 1991 Jan; 99(1):143-6. PubMed ID: 1670629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis.
    Jung M; Barra L
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):129-134. PubMed ID: 29799394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulsed doses of cyclophosphamide in the treatment of Wegener's granulomatosis].
    Kovacević Z; Mitrović D; Tomić I; Jovanović D; Skatarić V; Dimitrijević J; Rabrenović V; Trifunović G
    Vojnosanit Pregl; 1999; 56(1):31-7. PubMed ID: 10230331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.
    Lê Thi Huong D; Papo T; Piette JC; Wechsler B; Blétry O; Lamas G; Baumelou A; Le Hoang P; Pennaforte JL; Valcke JC; Godeau P
    Clin Exp Rheumatol; 1996; 14(1):9-16. PubMed ID: 8697666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing vasculitis--relapse despite cytotoxic therapy.
    Gordon M; Luqmani RA; Adu D; Greaves I; Richards N; Michael J; Emery P; Bacon PA
    Adv Exp Med Biol; 1993; 336():477-81. PubMed ID: 7905233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial vasculitis: report of 2 families.
    Rottem M; Cotch MF; Fauci AS; Hoffman GS
    J Rheumatol; 1994 Mar; 21(3):561-3. PubMed ID: 7911836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study.
    Drosos AA; Sakkas LI; Goussia A; Siamopoulos KC; Moutsopoulos HM
    J Intern Med; 1992 Sep; 232(3):279-82. PubMed ID: 1402626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.
    Hoffman GS; Leavitt RY; Fleisher TA; Minor JR; Fauci AS
    Am J Med; 1990 Oct; 89(4):403-10. PubMed ID: 2220874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide pulse therapy in Wegener's granulomatosis.
    Haubitz M; Frei U; Rother U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1991; 6(8):531-5. PubMed ID: 1956550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide.
    Cupps TR; Silverman GJ; Fauci AS
    Am J Med; 1980 Dec; 69(6):881-5. PubMed ID: 7446553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
    Haubitz M; Koch KM; Brunkhorst R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.